MT 100606
Alternative Names: MT-1006; MT-100606Latest Information Update: 28 Sep 2020
At a glance
- Originator Shaanxi Micot Technology Co
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders
Most Recent Events
- 08 Sep 2020 Early research in CNS disorders in China (Parenteral) (Shaanxi Micot Technology pipeline September 2020)